PE20140606A1 - Derivados de pirazol utiles como inhibidores de aldosterona sintasa - Google Patents

Derivados de pirazol utiles como inhibidores de aldosterona sintasa

Info

Publication number
PE20140606A1
PE20140606A1 PE2013002810A PE2013002810A PE20140606A1 PE 20140606 A1 PE20140606 A1 PE 20140606A1 PE 2013002810 A PE2013002810 A PE 2013002810A PE 2013002810 A PE2013002810 A PE 2013002810A PE 20140606 A1 PE20140606 A1 PE 20140606A1
Authority
PE
Peru
Prior art keywords
aldosterone synthase
synthase inhibitors
pyrazole derivatives
pyrazole
dimethyl
Prior art date
Application number
PE2013002810A
Other languages
English (en)
Spanish (es)
Inventor
Michael Gregory Bell
Paul J Hoogestraat
Thomas Edward Mabry
Quanrong Shen
Ana Maria Escribano
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=46317515&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140606(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of PE20140606A1 publication Critical patent/PE20140606A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PE2013002810A 2011-06-14 2012-06-07 Derivados de pirazol utiles como inhibidores de aldosterona sintasa PE20140606A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161496657P 2011-06-14 2011-06-14
US201161506349P 2011-07-11 2011-07-11

Publications (1)

Publication Number Publication Date
PE20140606A1 true PE20140606A1 (es) 2014-05-17

Family

ID=46317515

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002810A PE20140606A1 (es) 2011-06-14 2012-06-07 Derivados de pirazol utiles como inhibidores de aldosterona sintasa

Country Status (33)

Country Link
US (1) US8778984B2 (enExample)
EP (1) EP2721009B1 (enExample)
JP (1) JP5890012B2 (enExample)
KR (1) KR101555119B1 (enExample)
CN (1) CN103596930B (enExample)
AR (1) AR086665A1 (enExample)
AU (1) AU2012271023A1 (enExample)
BR (1) BR112013031873A2 (enExample)
CA (1) CA2836804C (enExample)
CL (1) CL2013003536A1 (enExample)
CO (1) CO6821955A2 (enExample)
CR (1) CR20130601A (enExample)
CY (1) CY1116687T1 (enExample)
DK (1) DK2721009T3 (enExample)
DO (1) DOP2013000284A (enExample)
EA (1) EA201391655A1 (enExample)
EC (1) ECSP13013080A (enExample)
ES (1) ES2548210T3 (enExample)
GT (1) GT201300307A (enExample)
HR (1) HRP20150939T1 (enExample)
HU (1) HUE026461T2 (enExample)
IL (1) IL229485A0 (enExample)
ME (1) ME02223B (enExample)
MX (1) MX336042B (enExample)
PE (1) PE20140606A1 (enExample)
PH (1) PH12013502597A1 (enExample)
PL (1) PL2721009T3 (enExample)
PT (1) PT2721009E (enExample)
RS (1) RS54269B1 (enExample)
SG (1) SG194822A1 (enExample)
SI (1) SI2721009T1 (enExample)
TW (1) TWI518073B (enExample)
WO (1) WO2012173849A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20170253577A1 (en) 2014-07-04 2017-09-07 Japan Tobacco Inc. Method for producing indole compound
CN108586221B (zh) * 2018-06-26 2021-03-02 常州制药厂有限公司 用于制备替卡格雷的中间体及其制备方法
CN112409432B (zh) * 2020-11-16 2023-07-07 陕西理工大学 一种依西美坦的合成方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57165369A (en) * 1981-04-06 1982-10-12 Teijin Ltd Pyrazole derivative and its preparation
US4617307A (en) 1984-06-20 1986-10-14 Ciba-Geigy Corporation Substituted imidazo[1,5-A]pyridine derivatives as aromatase inhibitors
US5057521A (en) 1988-10-26 1991-10-15 Ciba-Geigy Corporation Use of bicyclic imidazole compounds for the treatment of hyperaldosteronism
GT200600381A (es) * 2005-08-25 2007-03-28 Compuestos organicos
JPWO2007111175A1 (ja) 2006-03-17 2009-08-13 日本碍子株式会社 目封止ハニカム構造体の製造方法
EP2507234B1 (en) 2009-11-30 2014-03-12 Novartis AG Imidazole derivatives as aldosterone synthase inhibitors
CN102711916B (zh) 2010-01-14 2015-09-02 诺华股份有限公司 肾上腺激素调节剂的用途

Also Published As

Publication number Publication date
CA2836804A1 (en) 2012-12-20
AU2012271023A1 (en) 2013-11-28
ME02223B (me) 2016-02-20
MX2013014790A (es) 2014-01-24
EP2721009A1 (en) 2014-04-23
BR112013031873A2 (pt) 2016-12-13
KR20140009564A (ko) 2014-01-22
CL2013003536A1 (es) 2014-07-11
WO2012173849A1 (en) 2012-12-20
EP2721009B1 (en) 2015-08-12
PL2721009T3 (pl) 2016-01-29
KR101555119B1 (ko) 2015-09-22
CR20130601A (es) 2014-05-02
CN103596930B (zh) 2015-05-13
PH12013502597A1 (en) 2018-04-11
TW201311647A (zh) 2013-03-16
ES2548210T3 (es) 2015-10-14
JP2014517034A (ja) 2014-07-17
PT2721009E (pt) 2015-10-23
HUE026461T2 (en) 2016-05-30
DOP2013000284A (es) 2014-06-30
JP5890012B2 (ja) 2016-03-22
RS54269B1 (sr) 2016-02-29
DK2721009T3 (en) 2015-10-26
CN103596930A (zh) 2014-02-19
EA201391655A1 (ru) 2014-07-30
CA2836804C (en) 2016-05-24
NZ617642A (en) 2015-11-27
HRP20150939T1 (xx) 2015-10-09
ECSP13013080A (es) 2014-01-31
MX336042B (es) 2016-01-07
TWI518073B (zh) 2016-01-21
SG194822A1 (en) 2013-12-30
CO6821955A2 (es) 2013-12-31
CY1116687T1 (el) 2017-03-15
GT201300307A (es) 2014-11-24
US8778984B2 (en) 2014-07-15
US20120322841A1 (en) 2012-12-20
HK1193103A1 (en) 2014-09-12
IL229485A0 (en) 2014-01-30
AR086665A1 (es) 2014-01-15
SI2721009T1 (sl) 2015-10-30

Similar Documents

Publication Publication Date Title
ATE554085T1 (de) Neue inhibitoren von glutaminylcyclase
CY1119515T1 (el) Οξαζολο υποκατεστημενα ινδαζολια ως αναστολεις ρι3-κινασης
PE20141283A1 (es) Nuevos derivados biciclicos de dihidroisoquinolin-1-ona
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
ATE459622T1 (de) Tropanverbindungen
PE20171057A1 (es) Derivados espirodiamina como inhibidores de la aldosterona sintasa
EA201000100A1 (ru) Гетероциклические соединения, полезные в качестве ингибиторов mk2
PE20091842A1 (es) Pirrolidinonas como activadores de glucoquinasa
PE20140865A1 (es) Inhibidores de la tirosina-quinasa de bruton
EA201200653A1 (ru) Гетариламинохинолины
EA201391822A1 (ru) Новые производные пиридина
EA201101618A1 (ru) Арилпиридины в качестве ингибиторов альдостеронсинтазы
EA201001683A1 (ru) Производные фенил- или пиридинилзамещенных индазолов
EA201000561A1 (ru) Производные пиридина, пригодные в качестве активаторов глюкокиназы
EA201001358A1 (ru) Активаторы глюкокиназы
PE20121500A1 (es) 2-amino-5,5-difluor-5,6-dihidro-4h-oxazinas como inhibidores de bace 1 y/o bace 2
EA201391236A1 (ru) Новые циклические производные азабензимидазола, используемые в качестве антидиабетических агентов
TN2012000578A1 (en) Tetrahydro-pyrido-pyrimidine derivatives
EA200702363A1 (ru) Новые лиганды гистамина h-рецептора и их терапевтические применения
PH12012501630A1 (en) Pyrimidine derivatives and their use in the treatment of respiratory diseases such as copd
MX2009011205A (es) Derivados de 2-iminoisotiazol como ligandos del receptor canabinoide.
EA201290073A1 (ru) Соединения мочевины, содержащие 5,6-бициклический гетероарил, как ингибиторы киназ
BRPI0511933A (pt) derivados de quinazolinona úteis como antagonistas de vanilóide
EA201270280A1 (ru) Соединения пиримидина в качестве ингибиторов при лечении туберкулеза
EA201400822A1 (ru) Производные гетероциклических амидов в качестве антагонистов p2xрецептора

Legal Events

Date Code Title Description
FD Application declared void or lapsed